News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cubist Pharmaceuticals, Inc. (CBST) Selects TransPerfect Trial Interactive’s Trial Interactive Platform As Its eTMF Solution


6/16/2014 10:29:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--TransPerfect, a leading provider of e-clinical solutions and language services to the life sciences industry, today announced that Cubist has selected Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that integrates clinical documentation and trial development.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES